Skip to main content

The independent medical news service

17-08-2020 | Oncology | News | Article

COVID-19 pandemic leads to radiotherapy delays

Restrictive measures to limit the spread of COVID-19 have led to substantial disruptions to the radiotherapy schedules of patients with cancer, suggests a single-center chart review.

13-08-2020 | Oncology | News | Article

Fall in breast cancer screening, diagnosis, and treatment due to COVID-19

Rates of breast cancer surgery, imaging, and genetic testing in the USA have dropped during the COVID-19 pandemic, study findings suggest.

10-08-2020 | Oncology | News | Article

Considerations for conducting phase 1 trials in COVID-19 era proposed

A French team has put forward preliminary guidance for conducting phase 1 oncology clinical trials during the COVID-19 pandemic, including specific precautions for managing any participants with SARS-CoV-2.

06-08-2020 | Oncology | News | Article

COVID-19 treatments show minimal benefit in infected cancer patients

Results from the COVID-19 and Cancer Consortium show that a variety of treatments for COVID-19 have no significant positive impact on 30-day mortality in patients with invasive cancer.

03-08-2020 | Oncology | News | Article

Cancer patients with asymptomatic COVID-19 characterized

A Chinese report has shed light on the characteristics of cancer patients with asymptomatic SARS-CoV-2 infection.

29-07-2020 | Oncology | News | Article

ADT tied to reduced COVID-19 severity

Receipt of androgen deprivation therapy may be associated with less severe COVID-19 outcomes, suggest data from New York City.

27-07-2020 | Oncology | News | Article

Guidance proposed for managing breast cancer during COVID-19

A stage- and subtype-specific approach for the management of breast cancer during the COVID-19 outbreak has been published in JCO Oncology Practice.

24-07-2020 | Rheumatology | News | Article

ACR issues guidance on reinitiating RMD treatment following COVID-19 recovery

The American College of Rheumatology has released guidance on reinitiating treatment for rheumatic diseases following recovery from SARS-CoV-2 infection.

20-07-2020 | Oncology | News | Article

COVID-19 risk factors described for patients undergoing active anticancer treatment

Findings from a single Spanish center suggest that acute respiratory distress syndrome may be the main cause of death in patients undergoing active cancer treatment who are admitted to hospital for COVID-19.

13-07-2020 | Oncology | News | Article

Proposed protective effect of ADT on COVID-19 risk questioned

Two independent studies by Italian and Finnish researchers have found no association between androgen deprivation therapy and a reduced risk for COVID-19 in men with prostate cancer.

10-07-2020 | Oncology | News | Article

Cancer associated with COVID-19 mortality risk in large UK study

A large UK study using the OpenSAFELY analytics platform has found that people with cancer, particularly those with hematologic malignancies, may have an elevated risk for COVID-19-related death.

10-07-2020 | Rheumatology | News | Article

RA, SLE associated with COVID-19 mortality risk in large UK study

A large UK study using the OpenSAFELY analytics platform has identified autoinflammatory diseases including rheumatoid arthritis and systemic lupus erythematosus as possible risk factors for COVID-19-related death.

10-07-2020 | Oncology | News | Article

New York City data suggest link between immunotherapy, poor COVID-19 outcomes

Treatment with immune checkpoint inhibitors may increase the risk for poor outcomes among patients with cancer and comorbid SARS-CoV-2 infection, indicate data from New York City in the USA.

09-07-2020 | Diabetes | News | Article

​​​​​​​Diabetes associated with COVID-19 mortality risk in large UK study

A large UK study using the OpenSAFELY analytics platform has found that people with diabetes, particularly those with poor glycemic control, may have an elevated risk for COVID-19-related death.

03-07-2020 | Oncology | News | Article

Potential for anticancer, COVID-19 drug interactions highlighted

A French team has drawn attention to the potential for drug–drug interactions between anticancer medications and agents being used or tested for the treatment of COVID-19.

01-07-2020 | Oncology | News | Article

COVID-19: Oncology clinical trials enrollment falls

The COVID-19 outbreak is associated with a decrease in accrual to cancer clinical trials, indicate US data.

26-06-2020 | Oncology | News | Article

Lung cancer patient-specific factors ‘greatest determinants’ of COVID-19 severity

The burden of severe COVID-19 tends to be high in people with lung cancer, with patient-specific factors having the greatest impact on severity, indicates a chart review from a single center.

09-06-2020 | Diabetes | News | Article

Diabetes may present greatest risk to COVID-19 patients when newly diagnosed

Diabetes may present a higher risk to patients with COVID-19 if it is newly diagnosed at hospital admission rather than well established, indicates research from China.

07-06-2020 | Rheumatology | News | Article

EULAR issues provisional COVID-19 recommendations

EULAR has released provisional recommendations for the management of rheumatic diseases during the COVID-19 pandemic.

28-05-2020 | Rheumatology | News | Article

Lupus therapies may not impact COVID-19 outcomes

Two case series of patients with systemic lupus erythematosus and SARS-CoV-2 infection explore the association between baseline use of lupus medications and COVID-19 outcomes.

Image Credits